Radiation Oncology Market: Growth, Trends, Technology, Segmentation, and Future Outlook

The global Radiation Oncology Market is experiencing steady growth as cancer incidence continues to rise and healthcare providers increasingly adopt advanced radiation therapy technologies. Radiation oncology encompasses the equipment, software, treatment-planning systems, and services used to deliver and monitor radiation-based cancer treatments.

According to Kings Research, the global Radiation Oncology Market was valued at USD 8,567.2 million in 2023 and increased to an estimated USD 8,984.5 million in 2024. The market is projected to reach USD 13,160.3 million by 2031, registering a CAGR of 5.60% from 2024 to 2031.

Market expansion is being supported by rising cancer prevalence, increasing demand for minimally invasive treatment options, improved healthcare infrastructure, and technological advancements such as proton therapy, stereotactic radiosurgery, intensity-modulated radiation therapy (IMRT), and image-guided radiation therapy (IGRT).

What Is Radiation Oncology?

Radiation oncology is a specialized branch of cancer care that uses high-energy radiation to destroy or control cancer cells. Radiation can be delivered externally through machines such as linear accelerators or internally through a technique known as brachytherapy.

Modern radiation oncology goes beyond radiation delivery. It involves advanced imaging, treatment planning software, dose optimization, patient positioning, treatment monitoring, and image guidance to ensure that radiation reaches the tumor while minimizing exposure to surrounding healthy tissue.

Radiation therapy may be used as a primary treatment, after surgery, alongside chemotherapy, or for palliative care depending on the type and stage of cancer.

Key Growth Drivers of the Radiation Oncology Market

Rising Global Cancer Incidence

The increasing global burden of cancer is one of the strongest factors supporting demand for radiation oncology technologies and services. According to the collaborative cancer statistics cited by Kings Research, nearly 20 million new cancer cases and close to 10 million cancer-related deaths were recorded globally in 2022. Demographic projections indicate that annual cancer cases could reach approximately 35 million by 2050.

As the number of patients requiring cancer treatment increases, healthcare systems are investing in radiation therapy infrastructure, treatment centers, specialized equipment, and software.

Growing Adoption of Precision Radiotherapy

Precision medicine is transforming cancer treatment by enabling physicians to design therapies according to individual patient and tumor characteristics. Radiation oncology is benefiting from this trend through technologies that improve tumor targeting and dose delivery.

IMRT, IGRT, SBRT, proton therapy, and stereotactic radiosurgery allow radiation to be delivered more precisely, potentially reducing unnecessary exposure to healthy tissue.

Technological Advancements

Rapid innovation in radiation therapy equipment and treatment-planning software is creating new opportunities across the market. Advanced imaging systems, automated treatment planning, artificial intelligence, adaptive radiation therapy, and real-time image guidance are improving treatment workflows.

These innovations can help healthcare professionals make treatment more precise while improving operational efficiency.

Radiation Oncology Market Trends

Artificial Intelligence in Radiation Therapy

Artificial intelligence is becoming an important trend in radiation oncology. AI and machine learning can support treatment planning, image analysis, dose optimization, contouring, predictive modeling, and workflow automation.

Kings Research identifies AI integration as a significant market trend. In September 2024, GE HealthCare showcased AI-enhanced radiation therapy solutions, including Intelligent Radiation Therapy and other software designed to support precision treatment and personalized care.

AI can also help reduce repetitive tasks for clinical staff, which is particularly valuable in healthcare systems facing shortages of trained professionals.

Expansion of Image-Guided Radiation Therapy

Image-guided radiation therapy is becoming increasingly important because it enables treatment teams to verify tumor position before or during radiation delivery.

IGRT can improve treatment accuracy by accounting for patient movement and anatomical changes. The growing emphasis on precision and personalized treatment is expected to support continued adoption.

Growth of Stereotactic Treatments

Stereotactic radiosurgery and stereotactic body radiation therapy are gaining attention because they allow highly focused radiation doses to be delivered to tumors.

These approaches are particularly useful for selected tumors located in complex anatomical regions where protecting nearby healthy tissue is critical. Their increasing use is supporting demand for advanced radiation therapy systems.

Rise of Outpatient Radiation Therapy

Technological improvements are also supporting the expansion of outpatient radiation therapy. More efficient equipment, better treatment planning, and shorter treatment protocols can reduce the need for extended hospital stays.

This trend can improve patient convenience while helping healthcare facilities manage resources more efficiently.

Radiation Oncology Market Segmentation

By Type

Based on type, the Radiation Oncology Market is divided into:

• External Beam Radiation Therapy
• Internal Beam Radiation Therapy
• Software & Services

External beam radiation therapy includes technologies such as linear accelerators, proton therapy systems, Gamma Knife, and CyberKnife.

The external beam radiation therapy segment generated USD 6,397.1 million in 2023, making it the leading type segment. Its strong position is supported by widespread adoption and ongoing advances in technologies such as IMRT and IGRT.

Internal beam radiation therapy includes high-dose-rate and low-dose-rate brachytherapy. Software and services include treatment-planning systems and oncology information systems.

By Cancer Application

The market covers several major cancer applications, including:

• Breast Cancer
• Lung Cancer
• Prostate Cancer
• Colorectal Cancer
• Head and Neck Cancer
• Others

The prostate cancer segment accounted for 26.63% of the market in 2023 and is projected to reach USD 3,631.1 million by 2031. Its growth is associated with the prevalence of prostate cancer and the increasing use of radiation therapy as a primary or complementary treatment.

By Technology

Key radiation oncology technologies include:

• Intensity-Modulated Radiation Therapy (IMRT)
• Stereotactic Body Radiation Therapy (SBRT)
• Image-Guided Radiation Therapy (IGRT)
• Proton Therapy
• 3D Conformal Radiation Therapy (3D-CRT)

IMRT is expected to remain an important technology segment. Kings Research projects that the IMRT segment will generate USD 4,421.4 million by 2031, driven by its ability to precisely target tumors while limiting radiation exposure to surrounding tissues.

By End User

The major end users include:

• Hospitals
• Cancer Treatment Centers
• Research Institutes

Hospitals are expected to remain the dominant end-user segment. Kings Research estimates that the hospitals segment will reach USD 7,939.4 million by 2031, supported by rising cancer cases and increasing investment in advanced radiotherapy equipment.

Regional Analysis of the Radiation Oncology Market

North America

North America held the largest share of the global Radiation Oncology Market in 2023, accounting for 45.48%, equivalent to approximately USD 3,896.6 million.

The region benefits from advanced healthcare infrastructure, high healthcare spending, strong cancer research capabilities, and the presence of leading radiation oncology technology providers.

The U.S. is the primary contributor to regional demand due to its advanced cancer treatment infrastructure and high adoption of innovative radiotherapy technologies.

Strategic partnerships are also supporting market development. In September 2024, Varian entered into a 10-year partnership with Ballad Health to enhance oncology care in rural areas of the Appalachian Highlands through advanced radiotherapy solutions and oncology management systems.

Asia-Pacific

Asia-Pacific is expected to be the fastest-growing regional market, with Kings Research projecting a CAGR of 6.81% from 2024 to 2031.

Growth is being driven by increasing cancer incidence, expanding healthcare infrastructure, growing healthcare investments, and rising adoption of advanced medical technologies in China, India, Japan, South Korea, and other countries.

The region's large population and aging demographics are also increasing demand for cancer diagnosis and treatment services.

Europe

Europe represents an important market for radiation oncology because of its developed healthcare systems, strong cancer research ecosystem, and emphasis on radiation safety and clinical standards.

The region is witnessing increasing adoption of advanced technologies such as IMRT, IGRT, SBRT, and proton therapy. Healthcare providers are also focusing on improving treatment personalization and workflow efficiency.

Middle East, Africa, and South America

Emerging markets in the Middle East, Africa, and South America are expected to provide long-term growth opportunities as governments and healthcare organizations invest in cancer treatment infrastructure.

However, access to expensive radiation therapy equipment, skilled professionals, and specialized treatment centers remains a challenge in several developing countries.

Regulatory Environment

Radiation oncology is subject to strict regulatory and safety requirements because it involves ionizing radiation and complex medical equipment.

In the U.S., the Nuclear Regulatory Commission (NRC) oversees the licensing and use of radioactive materials, while the Food and Drug Administration (FDA) regulates medical devices, including radiation therapy equipment.

In China, the National Medical Products Administration (NMPA) regulates medical devices. Japan's Ministry of Health, Labour and Welfare (MHLW) oversees medical regulations, while professional organizations contribute to clinical guidelines.

In India, the Atomic Energy Regulatory Board (AERB) is responsible for regulating the safe use of ionizing radiation, including medical applications such as radiation oncology.

Challenges in the Radiation Oncology Market

Despite its growth potential, the market faces several challenges.

High Treatment Costs

Advanced radiation therapy systems can require substantial capital investment. Proton therapy systems, sophisticated linear accelerators, advanced imaging equipment, and treatment-planning software can be expensive to purchase and maintain.

High costs can limit adoption in low-income and developing regions.

Shortage of Skilled Professionals

Radiation oncology requires specialized professionals, including radiation oncologists, medical physicists, dosimetrists, radiation therapists, and specialized technicians.

A shortage of trained professionals can restrict the effective utilization of advanced equipment and create treatment delays.

Limited Access in Emerging Economies

Many developing countries continue to face shortages of radiation therapy equipment and specialized cancer centers. Improving affordability, training, infrastructure, and geographic accessibility will be essential for expanding the market.

Competitive Landscape

The Radiation Oncology Market is highly competitive, with companies focusing on technological innovation, strategic collaborations, product launches, acquisitions, and geographical expansion.

Major companies identified by Kings Research include:

• General Electric Company
• Siemens AG
• Elekta
• Accuray Incorporated
• AstraZeneca
• Hitachi Ltd.
• IBA Worldwide
• ViewRay Systems, Inc.
• Mevion Medical Systems
• Sumitomo Heavy Industries Ltd.
• Koninklijke Philips N.V.
• Nordion Inc.
• Telix Pharmaceuticals Limited
• Panacea Medical Technologies Pvt. Ltd.
• Advanced Accelerator Applications SA

Recent developments demonstrate the industry's focus on precision and automation. In May 2024, Elekta launched Elekta Evo, a CT-Linac system incorporating AI-enhanced imaging and adaptive radiation therapy capabilities. In December 2024, Varian received FDA clearance for its RapidArc Dynamic solution, which Kings Research reports can reduce optimization time substantially.

Future Outlook

The future of the Radiation Oncology Market is expected to be shaped by the convergence of advanced imaging, AI, precision medicine, automation, and adaptive radiation therapy.

AI-powered treatment planning could make workflows faster and more consistent, while adaptive radiation therapy can enable treatment plans to be adjusted according to changes in patient anatomy during a treatment course.

Proton therapy and other highly precise radiation technologies are also expected to attract investment, particularly for applications where minimizing radiation exposure to healthy tissues is important.

Emerging markets represent another major opportunity. As cancer treatment infrastructure expands across Asia-Pacific, Latin America, the Middle East, and Africa, demand for radiation therapy equipment, software, and specialized services is expected to increase.

Conclusion

The Radiation Oncology Market is positioned for sustained growth as cancer incidence rises and healthcare providers increasingly adopt precision-based treatment technologies. Kings Research estimates that the market will increase from USD 8,984.5 million in 2024 to USD 13,160.3 million by 2031, representing a 5.60% CAGR.

External beam radiation therapy currently represents the largest type segment, while IMRT, IGRT, SBRT, proton therapy, and AI-enabled treatment planning are reshaping the industry. North America remains the leading regional market, whereas Asia-Pacific is expected to record the fastest growth.

As healthcare systems continue investing in advanced cancer care, the combination of precision radiation therapy, artificial intelligence, adaptive treatment, and improved imaging is expected to create significant opportunities for technology providers, hospitals, cancer treatment centers, and research organizations worldwide.